Clinical trial tests natural killer cells on pediatric brain tumors
The most common malignant brain tumors in children, medulloblastomas, are usually incurable if they recur. Even with surgery, chemotherapy, radiation and stem cell transplantation, children with recurrent medulloblastoma have a two-year overall survival rate of less than 20%.To improve these odds, MD Anderson researchers are testing a new therapy that infuses natural killer (NK) cells directly into the brain. The clinical trial...
